Metformin, a widely used and affordable diabetes drug, could prevent a form of acute myeloid leukemia in people at high risk ...

Family and friends of Rachel Simon of Hazlet are staging events to find a bone marrow donor who can help her fight off ...

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains ...

Widely used drug could prevent leukaemia among those at risk - People at high risk of acute myeloid leukaemia (AML) can be ...

Exicure to initiate new clinical trial in acute myeloid leukaemia with GPC-100: Redwood City, California Tuesday, April 15, 2025, 18:00 Hrs [IST] Exicure, Inc., an early-stage bio ...

Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the ...

Research doesn't happen by accident. Clinical trials don't appear overnight. Every treatment we use at the bedside starts ...

Aug. 21, 2024 — An international team of scientists has uncovered a mechanism by which acute myeloid leukemia (AML) cells sustain their growth. AML cells prevent the synthesis of proteins that ...

This gives hope for a potential treatment for those at high risk of developing the disease.

Autolus has picked up its first product approval, getting an FDA green light for Aucatzyl as a treatment for patients with aggressive blood cancer acute lymphoblastic leukaemia (ALL). The US ...